NRXS - Neuraxis, INC

QQQ $ 612.14 $ 1.56 (0.26 %)

DIA $ 470.45 $ 1.64 (0.35 %)

SPY $ 672.31 $ 2.95 (0.44 %)

TLT $ 89.45 $ -0.19 (-0.21 %)

GLD $ 367.77 $ 0.35 (0.1 %)

Previous Close

$ 2.54

Open

$ 2.48

Bid

$ 2.40 x 60

Ask

$ 2.60 x 40

Day's Range

$ 2.40 - $ 2.61

52 Week Range

$ 1.33 - $ 6.20

Volume

86,065

Average Volume

Market Cap

25.04M

Beta (5Y Monthly)

$ 1.39

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-20-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-20-2024	03-31-2024	10-Q
7	04-16-2024	12-31-2023	10-K
8	11-20-2023	09-30-2023	10-Q
9	09-22-2023	06-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Friday's P...
10/24/2025 12:07:33

NeurAxis Receives FDA Clearance For Its Pe...
10/24/2025 12:06:43

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...

12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Neuraxis Q2 EPS $(0.22) Beats $(0.23) Esti...
08/12/2025 11:05:49

Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.23) by 4.3...

Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

Earnings Outlook For Neuraxis
08/11/2025 18:03:25

12 Health Care Stocks Moving In Monday's A...
07/21/2025 21:06:05

Craig-Hallum Initiates Coverage On Neuraxi...
06/16/2025 15:25:40

Craig-Hallum analyst Chase Knickerbocker initiates coverage on Neuraxis (AMEX:NRXS) with a Buy rating and announces Price Ta...

NeurAxis Says Proprietary PENFS Technology...
06/10/2025 12:03:11

Practice guidelines published in the Journal of Pediatric Gastroenterology & Nutrition (JPGN) name Percutaneous Electrical ...

NeurAxis Enters Into Definitive Agreements...
05/21/2025 11:02:29

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...

gold-gains-over-1-amer-sports-posts-upbeat-earnings

Gold Gains Over 1%; Amer Sports Posts Upbe...
05/20/2025 16:13:58

nasdaq-falls-100-points-home-depot-sales-top-views

Nasdaq Falls 100 Points; Home Depot Sales ...
05/20/2025 14:01:03

NeurAxis Receives FDA 510(K) Clearance For...
05/20/2025 12:05:52

• Significantly expands IB-Stim's total addressable market• Clearance covers patients aged 8–21• Seamless go-to-marke...

CORRECTION: Neuraxis Q1 EPS $(0.33) Down F...
05/12/2025 12:43:18

Earnings Scheduled For May 12, 2025
05/12/2025 08:32:31

Neuraxis Q4 EPS $(0.23) Up From $(0.85) Yo...
03/20/2025 12:07:25

Neuraxis (AMEX:NRXS) reported quarterly losses of $(0.23) per share. This is a 72.94 percent increase over losses of $(0.85) pe...

Earnings Scheduled For March 20, 2025
03/20/2025 08:32:14

NeurAxis Announces Molina Healthcare Cover...
01/21/2025 14:06:34

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...

NeurAxis CEO Brian Carrico Issues Letter T...
01/13/2025 14:15:43

Dear shareholders,We are thrilled to connect with you as we celebrate NeurAxis's remarkable achievements in 2024 and antici...

NeurAxis Sees Q4 Revenues ~$800K, Up 50% YoY
01/08/2025 14:02:08